Multipel Skleros En kartläggning av infektionskomplikationer i samband med hematopoetisk stamcellstransplantation

Sammanfattning: ABSTRACT Multiple sclerosis (MS) is the leading cause of adult disability inSweden. Hematopoietic stem cell transplantation (HSCT) can be used as a treatment option for patients with MS where the disease has an aggressive course. The treatment is preceded by high-dose chemotherapy which lowers the patient's immune system. It is therefore of interest to study infectious complications associated with HSCT in this patient. Aim: The purpose of this study was to identify infection problems in this population associated with HSCT, and to study differences in infectious complications between this group and patients diagnosed with lymphoma who have undergone the same treatment.Method: The study was a retrospective descriptive study with quantitative data. A medical record review was conducted. The analysis of the results was used Statistical Package for the Social Sciences (SPSS) version 19th Independent t-tests were used as the statistical analysis to measure the difference between two groups at the same time.Result: The results showed that there were differences in fever period. Patients with MS had a significantly longer fever period than patients with lymphoma. It did not affect the number of days in hospital. Patients with MS had a shorter period of neutropenia but significantly more positive blood cultures.Conclusion: Patients with MS who are treated with HSCT are at high risk of infection. The risk of infectious complications is greater than in patients treated for lymphoma. We need to consider this finding to the clinical management of patients with MS associated with HSCT.   “Keywords: multiple sclerosis, hematopoietic stem cell transplantation, infection, complicationn”